Our team focuses exclusively on the care of patients with lymphoid blood cancers (non-Hodgkin’s lymphoma and Hodgkin’s disease). It is now estimated that there are over 70 different types of lymphoid cancers, a spectrum of disease that encompasses some of the fastest and slowest growing diseases known to science.
The physicians and other care team members have extensive experience managing both Hodgkin lymphoma and all forms of non-Hodgkin’s lymphoma (NHL), including:
- Peripheral T-cell Lymphoma (PTCL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- Mantle Cell Lymphoma (MCL)
- Follicular Lymphoma (FL)
- Chronic Lymphocytic Leukemia (CLL)
- Acute Lymphoblastic Leukemia/Lymphoma (ALL)
- Cutaneous T-cell Lymphoma
- Lymphomas of the brain
The HICCC houses one of the largest portfolios of clinical trials in the nation for patients with lymphoma and lymphoid leukemia. Because our physicians are contributing to the development of new ways to manage these diseases, they are at the forefront of knowing the latest emerging trends in lymphoma care--usually well before this information becomes available to the general public or even the medical community.
With advanced radiation therapy techniques doctors can better target tumors while reducing the radiation to nearby healthy tissues. Here at HICCC our radiation oncology experts have the ability to provide “state of the art” treatments for Lymphoma.
Your radiation oncologist will design the optimal treatment plan with you to ensure you achieve the best outcomes. Treatment delivery can be daily, weekly, every other day, and or single fraction.
If radiation treatment is recommended, a radiation oncologist will work with our radiation oncology team to create a course of treatment. At the HICCC, treatment modalities available and most commonly used for this cancer are External Beam Radiation Therapy, 3D Conformal Radiotherapy, Image Guided Radiation Therapy (IGRT) and Intensity modulated radiation therapy (IMRT).